Cargando…
Cancer-specific glycosylation of CD13 impacts its detection and activity in preclinical cancer tissues
Harnessing the differences between cancer and non-cancer tissues presents new opportunities for selective targeting by anti-cancer drugs. CD13, a heavily glycosylated protein, is one example with significant unmet clinical potential in cancer drug discovery. Despite its high expression and activity...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628746/ https://www.ncbi.nlm.nih.gov/pubmed/37942010 http://dx.doi.org/10.1016/j.isci.2023.108219 |